Skin News and Research

RSS

EP-100 membrane-disrupting peptide drug for cancer being tested at TCRS

A new drug designed to "seek and destroy" common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.

6 Oct 2009

Winner of 2009 NAMS award

Michael Holick, PhD, MD, director of the Bone Healthcare Clinic and the Vitamin D, Skin and Bone Research Laboratory at Boston University School of Medicine BUSM recently received the 2009 NAMS/Upsher-Smith Laboratories, Inc.Vitamin D Research Award from the North American Menopause Society (NAMS).

6 Oct 2009

Depression leads to elevated inflammatory proteins in the human body: Study

To help solve this long standing chicken and egg conundrum, researchers led by Jesse Stewart, Ph.D., assistant professor of psychology at Indiana University-Purdue University Indianapolis asked two critical questions. Does depression lead to elevated inflammatory proteins in the human body? Or does an increase in these proteins lead to depression? They found that the answer to the first question appears to be "yes," and the answer to the second question may be "no" among healthy adults.

6 Oct 2009

Butler Hospital leads clinical study for effectiveness and safety of DBS for OCD

Butler Hospital in Providence, R.I., is leading a clinical study evaluating the effectiveness and safety of deep brain stimulation (DBS) for severe obsessive-compulsive disorder (OCD).

6 Oct 2009

News outlets examines health impact of disasters in Indonesia, Samoa, Philippines

In Indonesia, "[r]escue workers called off the search Monday for life under the rubble left by a massive earthquake, focusing instead on bringing aid to survivors," the Agence France-Presse reports. "The United Nations has said at least 1,100 people were killed in the disaster, but estimates of the final toll range up to 5,000. The official toll stood at 650 dead and 672 missing, according to the health ministry," the news service writes (Belford, 10/5).

6 Oct 2009

Wellstar International update on the Duke Study for predicting nosocomial pressure ulcers

The study was designed to determine that long-wave infrared imaging can be used to identify skin temperature changes associated with underlying tissue changes. We wanted to determine if the use of Long Wave infrared imaging is as effective as the Braden Score in predicting nosocomial pressure ulcers.

5 Oct 2009

SAGE SOLUTIONS announces market release of Drain Pouch Management Gown

SAGE SOLUTIONS, INC. today announced the market release of its Drain Pouch Management Gown™ (DPM Gown™), a uniquely engineered patient gown, designed to manage drain bulb pouches during post-surgical recovery. The DPM Gown™ features patent pending, two-way pockets that securely hold drain bulbs in place.

5 Oct 2009

Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP

Baxter International Inc. today announced the commercial launch of HYLENEX recombinant (hyaluronidase human injection) for use in pediatric rehydration at the 2009 American College of Emergency Physicians (ACEP) scientific assembly (Boston). HYLENEX, an enzyme, allows fluids to be administered under the skin (subcutaneously) rather than through a vein.

From Baxter International Inc. 5 Oct 2009

New consumer At-Home Skin Typing and Analysis Kit unveiled

Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.

5 Oct 2009

avVaa World Health Care Products launches Neuroskin Psoriasis Relief DRTV media test campaign

avVaa World Health Care Products Inc. a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the launch of its two week Neuroskin(R) Psoriasis Relief DRTV media test campaign.

5 Oct 2009

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.

5 Oct 2009

Myocardial and neurological effects of Tβ4 presented

REGENERX BIOPHARMACEUTICALS, INC. today reported on the results of several important research programs with Thymosin beta 4 (Tβ4) presented at the Second International Symposium on Thymosins in Health and Disease, in Catania, Italy.

5 Oct 2009

Top ten sleep and beauty tips

Bob Hickman, United Feather & Down's Senior Vice Present of Sales and Marketing, and Neil A. Petrocelli, Borghese, Inc.'s Vice President of Marketing, list their top sleep and beauty tips.

5 Oct 2009

Nationwide Children's Hospital study on burn injuries in kids

In the next 60 seconds, another child will be on his/her way to the hospital to be treated for serious burns; it happens more than 300 times a day in this country. Now, one of the largest studies ever done on burn injuries in kids is out from experts at Nationwide Children's Hospital and the results are mixed: while overall injuries are down, there are some kids who are still at serious risk.

5 Oct 2009

Burns: A common cause of pediatric injury

Burns are a common cause of pediatric injury worldwide, typically resulting from hot water, flames, hot surfaces, chemicals and electrical appliances. A recent study conducted by the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital, found that from 1990-2006 more than 2 million children younger than 21 were treated in hospital emergency departments for burn-related injuries.

5 Oct 2009

Skin News and Research

EP-100 membrane-disrupting peptide drug for cancer being tested at TCRS

Winner of 2009 NAMS award

Depression leads to elevated inflammatory proteins in the human body: Study

Butler Hospital leads clinical study for effectiveness and safety of DBS for OCD

News outlets examines health impact of disasters in Indonesia, Samoa, Philippines

Wellstar International update on the Duke Study for predicting nosocomial pressure ulcers

SAGE SOLUTIONS announces market release of Drain Pouch Management Gown

Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP

New consumer At-Home Skin Typing and Analysis Kit unveiled

avVaa World Health Care Products launches Neuroskin Psoriasis Relief DRTV media test campaign

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

Myocardial and neurological effects of Tβ4 presented

Top ten sleep and beauty tips

Nationwide Children's Hospital study on burn injuries in kids

Burns: A common cause of pediatric injury

PDT-PCI combination with ENVIRON Surgical Roll-CIT effective for treating facial acne scars

Blepharoplasty increases patients' quality of life

Minnesota Hospital Association announces winners of the Patient Safety Excellence Awards

Ontario government's promise regarding UV radiation from artificial tanning equipment not fulfilled

Clinical study data of Thymosin beta 4 presented

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News